Zaragoza-Vargas PE, Herrera M, Piris MA, Padilla-Rodríguez AL, Ortiz-Hidalgo C

Language: Spanish
References: 20
Page: 49-55
PDF size: 207.88 Kb.

ABSTRACT

The gastrointestinal tract is one of the most frequent sites of extranodal malignant lymphoma, being the stomach the most common affected site. Primary small intestinal lymphoma, however, it is very uncommon accounting for 19 to 38% of small bowel malignancies and 4 to 12% of all non-Hodgkin lymphomas. We report the immunohistochemical and molecular study of an extranodal marginal zone B-cell lymphoma of the jejunal mucosa associated lymphoid tissue (MALT lymphoma), that presented as an incidental fi nding in a morbidly obese patient.

REFERENCES

1. Riddell RH, Petras RE, Williams GT, Sobin LH. Atlas of tumor pathology. Tumours of Intestines. Washington, Third series, Fascicle 32. Washington, DC. Armed Forces Institute of Pathology 2003;pp:400-4.

2. Isaacson PG, Chott A, Nakamura S, Müller-Hermelik HK, et al. Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma). Lyon. International Agency for Research on Cancer. World Health Organization, 2007; pp:214-7.

3. Al-Saleem T, Zardawi IM. Primary lymphomas of small intestine in Iraq: a pathological study of 145 cases. Histopathology 1979;3:89-106.

4. Isaacson P, Wright DH. Malignant lymphoma of mucosa associated lymphoid tissue: a distinctive type of B- cell lymphoma. Cancer 1983;52:1410-6.

5. Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B- cell neoplasms. Blood 2005;105:2274-80.

6. Isaacson PG. Wright DH. Extranodal malignant lymphoma arising from mucosa associated lymphoid tissue. Cancer 1984;53:2515-24.

7. Piña-Oviedo S, Ortiz-Hidalgo C. Linfoma de células B de la zona marginal extraganglionar del tejido linfoide asociado a mucosas (linfoma MALT). Evolución histórica y conceptos actuales. Gac Med Mex 2007;14:237-4.

8. Dilworth HP. Neoplasms of the small intestine. In: Lacobuzio- Danahue CA, Montgomery EA, editors. Gastrointestinal and Liver Pathology. Philadelphia: Churchill-Livingstone Elsevier, 2005;pp:174-234.

9. Bacon CM, Du MQ, Dogan A. Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists. J Clin Pathol 2007;60:361-72.

10. Wotherspoon A, Ortiz-Hidalgo C, Falzon M, Isaacson PG. Helicobacter pylori-associated gastritis and primary gastric B-cell lymphoma. Lancet 1991;338:1175-6.

11. Nagashima R, Takeda H, Maeda K, Ohno S, Takahashi T.Regression of duodenal mucosa associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. Gastroenterol 1996;111:1674-8.

12. Fishbach W, Tacke W, Greiner A, Müller-Hermelink HK. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet 1997;349:31-32.

13. Alkan S, Karcher DS, Newman MA, Cohen P. Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet 1996;348:268-9.

14. Thomas JE, Gibson GR, Darboe MK, Dale A, Weaver LT. Isolation of Helicobacter pylori from human feces. (See comment). Lancet 1992;340:1194-5.

15. Keung YK, Higgs V, Albertson DA, Cappellari JO. Mucosaassociated lymphoid tissue (MALT) lymphoma of jejunum and Helicobacter pylori-chance association? Leuk Lymphoma 2003;44:1413-6.

16. Kernéis S, Bogdanova A, Kraehenbuhl JP, Pringault E. Conversion by Peyer’s patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997;277:949- 52.

17. Doi Y, Goto A, Murakami T, Yamashita H, Noguchi S. Primary thyroid lymphoma associated with Graves’ disease. Thyroid 2004;14:772-6.

18. Inagaki H. Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological signifi cance. Pathol Int 2007;57:474-84.

19. Du MQ. MALT Lymphoma. Recent advances in aetiology and molecular genetics. J Clin Exp Hematopathol 2007;47:31-42.

20. Nakamura S. Matsumoto T. A clinicopathologic study of primary small intestine lymphoma: Prognostic signifi cance of mucosa associated lymphoid tissue-derived lymphoma. Cancer 2000;88:286-94.